A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (t (Q35527102)
Jump to navigation
Jump to search
scientific article published on 20 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (t |
scientific article published on 20 September 2011 |
Statements
1 reference
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (t (English)
1 reference
C Chouaid
1 reference
H LeCaer
1 reference
F Barlesi
1 reference
R Corre
1 reference
H Jullian
1 reference
S Bota
1 reference
L Falchero
1 reference
A Vergnenegre
1 reference
C Dujon
1 reference
J Y Delhoume
1 reference
GFPC 0504 Team
1 reference
20 September 2011
1 reference
1 reference
105
1 reference
8
1 reference
1123-1130
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference